» Articles » PMID: 37080969

Integrated Transcriptome Landscape of ALS Identifies Genome Instability Linked to TDP-43 Pathology

Abstract

Amyotrophic Lateral Sclerosis (ALS) causes motor neuron degeneration, with 97% of cases exhibiting TDP-43 proteinopathy. Elucidating pathomechanisms has been hampered by disease heterogeneity and difficulties accessing motor neurons. Human induced pluripotent stem cell-derived motor neurons (iPSMNs) offer a solution; however, studies have typically been limited to underpowered cohorts. Here, we present a comprehensive compendium of 429 iPSMNs from 15 datasets, and 271 post-mortem spinal cord samples. Using reproducible bioinformatic workflows, we identify robust upregulation of p53 signalling in ALS in both iPSMNs and post-mortem spinal cord. p53 activation is greatest with C9orf72 repeat expansions but is weakest with SOD1 and FUS mutations. TDP-43 depletion potentiates p53 activation in both post-mortem neuronal nuclei and cell culture, thereby functionally linking p53 activation with TDP-43 depletion. ALS iPSMNs and post-mortem tissue display enrichment of splicing alterations, somatic mutations, and gene fusions, possibly contributing to the DNA damage response.

Citing Articles

Stem Cell Therapy for the Treatment of Amyotrophic Lateral Sclerosis: Comparison of the Efficacy of Mesenchymal Stem Cells, Neural Stem Cells, and Induced Pluripotent Stem Cells.

Frawley L, Taylor N, Sivills O, McPhillamy E, To T, Wu Y Biomedicines. 2025; 13(1).

PMID: 39857620 PMC: 11763168. DOI: 10.3390/biomedicines13010035.


Inferring gene regulatory networks of ALS from blood transcriptome profiles.

Pappalardo X, Jansen G, Amaradio M, Costanza J, Umeton R, Guarino F Heliyon. 2024; 10(23):e40696.

PMID: 39687198 PMC: 11648123. DOI: 10.1016/j.heliyon.2024.e40696.


repeat expansion creates the unstable folate-sensitive fragile site FRA9A.

Mirceta M, Schmidt M, Shum N, Prasolava T, Meikle B, Lanni S NAR Mol Med. 2024; 1(4):ugae019.

PMID: 39669124 PMC: 11632612. DOI: 10.1093/narmme/ugae019.


Human VCP mutant ALS/FTD microglia display immune and lysosomal phenotypes independently of GPNMB.

Clarke B, Ziff O, Tyzack G, Petric Howe M, Wang Y, Klein P Mol Neurodegener. 2024; 19(1):90.

PMID: 39593143 PMC: 11590569. DOI: 10.1186/s13024-024-00773-1.


Regulation of TAR DNA binding protein 43 (TDP-43) homeostasis by cytosolic DNA accumulation.

Yang C, Leifer C, Lammerding J, Hu F J Biol Chem. 2024; 300(12):107999.

PMID: 39551138 PMC: 11719319. DOI: 10.1016/j.jbc.2024.107999.


References
1.
Lee K, Suzuki H, Aiso S, Matsuoka M . Overexpression of TDP-43 causes partially p53-dependent G2/M arrest and p53-independent cell death in HeLa cells. Neurosci Lett. 2011; 506(2):271-6. DOI: 10.1016/j.neulet.2011.11.021. View

2.
Ewels P, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A . The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020; 38(3):276-278. DOI: 10.1038/s41587-020-0439-x. View

3.
Humphrey J, Venkatesh S, Hasan R, Herb J, de Paiva Lopes K, Kucukali F . Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes. Nat Neurosci. 2022; 26(1):150-162. DOI: 10.1038/s41593-022-01205-3. View

4.
Dafinca R, Barbagallo P, Farrimond L, Candalija A, Scaber J, Ababneh N . Impairment of Mitochondrial Calcium Buffering Links Mutations in C9ORF72 and TARDBP in iPS-Derived Motor Neurons from Patients with ALS/FTD. Stem Cell Reports. 2020; 14(5):892-908. PMC: 7220989. DOI: 10.1016/j.stemcr.2020.03.023. View

5.
Prudencio M, Humphrey J, Pickles S, Brown A, Hill S, Kachergus J . Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J Clin Invest. 2020; 130(11):6080-6092. PMC: 7598060. DOI: 10.1172/JCI139741. View